The global alzheimer’s therapeutics market share analysis is projected to reach approximately USD 4,288.82 million by 2025, fueled by significant investments in research and development (R&D) and strategic collaborations aimed at advancing novel treatments. Leading pharmaceutical firms are heavily investing in breakthrough therapeutics targeting amyloid plaques and tau proteins, the key pathological markers of Alzheimer’s …